Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103524575A details a green synthesis route for beta-arbutin, offering significant cost reduction in skin whitening agent manufacturing through solvent recycling.
Patent CN107188792A reveals a novel [4+2] cyclization for 2,4'-dihydroxybenzophenone. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN116199597B reveals a novel diazonium salt catalyst enabling mild synthesis of indole derivatives with substantial cost and supply chain advantages for global buyers.
Patent CN102603566B details a room-temperature asymmetric synthesis of chiral amino nitriles using copper catalysis, offering mild conditions for pharmaceutical intermediate manufacturing.
Patent CN101857566B reveals a novel one-pot method for 2-hydroxypyridines, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Advanced synthesis of soluble polymer-supported chiral auxiliaries from L-tyrosine. Enhances asymmetric induction efficiency and simplifies purification for pharmaceutical manufacturing.
Patent CN101591328A details a green bromination process for 2-bromothiophene derivatives, offering high purity and recyclable reagents for cost-effective manufacturing.
Patent CN102442973A details a green one-pot synthesis of benzimidazoles from primary alcohols using TEMPO and air, offering significant cost reduction in API manufacturing.
Patent CN108164435B details a solvent-free, Ru/C-catalyzed route for arylacrylonitriles, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed regioselective 1,4-sulfocyanation for efficient allene nitrile production. Reduces steps and cost for API manufacturing.
Patent CN118388328A enables green aldehyde ketone production via photochemical decarboxylation. Offers cost reduction and high purity for supply chains.
Novel one-step synthesis avoids chlorine gas hazards. High yield, mild conditions ensure reliable supply for pharma intermediates manufacturing and cost reduction.
Novel organocatalysts for asymmetric aldol reactions offering high ee/dr and recyclability for pharmaceutical intermediate manufacturing.
Patent CN106220509B reveals ionic liquid catalysis for xanthene diones. Solvent-free, room temp process offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN106588787A details Pd-catalyzed synthesis of aroyl triazoles. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN113999084A details a novel asymmetric synthesis of (S)-nicotine via myosmine reduction, offering high purity and cost-effective manufacturing for reliable suppliers.
Patent CN113527081B reveals a safer Mitsunobu route for 3-oxocyclobutanecarboxylic acid. Discover cost reduction in pharma intermediate manufacturing and scalable supply solutions.
Novel metal-free synthesis of methylthiomethyl esters using DMSO. Cost-effective, scalable pharmaceutical intermediate manufacturing with high purity standards.
Novel blue-light mediated method for ((alkylamino)methyl)diphenylphosphine oxides. Mild conditions, high purity, scalable process for pharma intermediates.
Patent CN112939903A reveals a novel Ti-catalyzed, solvent-free route to polysubstituted furans, offering significant cost reduction and scalable manufacturing for pharma intermediates.